Diabetes Mellitus Clinical Trial
NCT number | NCT00006331 |
Other study ID # | NCRR-M01RR00042-1699 |
Secondary ID | M01RR000042 |
Status | Recruiting |
Phase | N/A |
First received | October 4, 2000 |
Last updated | June 27, 2005 |
Research participants will be asked to undergo complete medical history, physical
examination and blood tests. The purpose of these tests is to determine whether persons are
predisposed to develop diabetes mellitus after kidney transplantation and also to make an
early diagnosis if a patient develops diabetes mellitus. Medical information collected as
part of the standard transplant evaluation and posttransplant medical care may be
incorporated into this study. It is important to realize that research subjects will not be
given an experimental drug as part of this study.
After kidney transplantation, research subjects will be followed in the posttransplant
clinic visits. The study will last up to 6 months. During this time the subjects may be
asked to participate in clinical assessment visits (medical history and physical
examination), and also during the third or fourth month after transplant will be asked to do
a repeat glucose tolerance test.
Status | Recruiting |
Enrollment | 0 |
Est. completion date | |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Fasting Plasma Glucose (FPG) <126mg/dl. - No history of diabetes mellitus or treatment with oral antidiabetic agent or insulin. - ESRD or chronic renal failure with CrCl <= 20cc/min per 1.73m2. - Waiting list registration for cadaveric or set date for living donor renal transplantation. - Willingness and ability to understand and give informed consent. |
Observational Model: Defined Population, Time Perspective: Longitudinal
Country | Name | City | State |
---|---|---|---|
United States | 3914 Taubman Center | Ann Arbor | Michigan |
Lead Sponsor | Collaborator |
---|---|
National Center for Research Resources (NCRR) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03743779 -
Mastering Diabetes Pilot Study
|
||
Completed |
NCT03786978 -
Pharmaceutical Care in the Reduction of Readmission Rates in Diabetes Melitus
|
N/A | |
Completed |
NCT01804803 -
DIgital Assisted MONitoring for DiabeteS - I
|
N/A | |
Completed |
NCT05039970 -
A Real-World Study of a Mobile Device-based Serious Health Game on Session Attendance in the National Diabetes Prevention Program
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT04068272 -
Safety of Bosentan in Type II Diabetic Patients
|
Phase 1 | |
Completed |
NCT03243383 -
Readmission Prevention Pilot Trial in Diabetes Patients
|
N/A | |
Completed |
NCT03730480 -
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
|
N/A | |
Recruiting |
NCT02690467 -
Efficacy, Safety and Acceptability of the New Pen Needle 34gx3,5mm.
|
N/A | |
Completed |
NCT02229383 -
Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus
|
Phase 3 | |
Completed |
NCT06181721 -
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Patients With Type 1 and Type 2 Diabetes
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT04489043 -
Exercise, Prediabetes and Diabetes After Renal Transplantation.
|
N/A | |
Withdrawn |
NCT03319784 -
Analysis for NSAID VS Corticosteroid Shoulder Injection in Diabetic Patients
|
Phase 4 | |
Completed |
NCT03542084 -
Endocrinology Auto-Triggered e-Consults
|
N/A | |
Completed |
NCT02229396 -
Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo
|
Phase 3 | |
Recruiting |
NCT05544266 -
Rare and Atypical Diabetes Network
|
||
Completed |
NCT01892319 -
An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Insulin Detemir in Pregnant Women With Diabetes Mellitus. Diabetes Pregnancy Registry
|
||
Completed |
NCT05031000 -
Blood Glucose Monitoring Systems: Discounter Versus Brand
|
N/A | |
Recruiting |
NCT04039763 -
RT-CGM in Young Adults at Risk of DKA
|
N/A |